Drug-Pricing Help Wanted: Wyden, Grassley Seek Public Input On Policy Ideas
This article was originally published in The Pink Sheet Daily
Executive Summary
Following their 2015 report on Gilead's pricing methodology for Sovaldi and Harvoni, senators ask for comments on how to measure value and improve price transparency.